Nasdaq
RTTNews) – British drug maker AstraZeneca Plc (AZN.L, AZN) announced Monday that the European Commission has approved Tagrisso (osimertinib) to treat adult patients with locally advanced, unresectable non-small cell lung cancer or NSCLC in the European Union…
Read More
AstraZeneca’s Tagrisso Gets EU Approval For Unresectable EGFR-mutated Lung Cancer
RTTNews
12:19
RTTNews) – British drug maker AstraZeneca Plc (AZN.L, AZN) announced Monday that the European Commission has approved Tagrisso (osimertinib) to treat adult patients with locally advanced, unresectable non-small cell lung cancer or NSCLC in the European Union…
